Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Place Cells | 6 | 2022 | 18 | 3.410 |
Why?
|
| Hippocampus | 19 | 2025 | 861 | 3.070 |
Why?
|
| Visual Cortex | 4 | 2021 | 131 | 1.670 |
Why?
|
| Wakefulness | 5 | 2024 | 104 | 1.610 |
Why?
|
| Action Potentials | 10 | 2025 | 521 | 1.580 |
Why?
|
| Neurons | 13 | 2025 | 2050 | 1.370 |
Why?
|
| Spatial Memory | 4 | 2022 | 32 | 1.300 |
Why?
|
| Sleep | 3 | 2024 | 369 | 1.050 |
Why?
|
| Behavior, Animal | 6 | 2025 | 522 | 0.960 |
Why?
|
| Memory Consolidation | 1 | 2024 | 12 | 0.890 |
Why?
|
| Rats | 13 | 2025 | 3851 | 0.840 |
Why?
|
| Grid Cells | 1 | 2022 | 3 | 0.810 |
Why?
|
| CA1 Region, Hippocampal | 4 | 2021 | 81 | 0.790 |
Why?
|
| Spatial Behavior | 2 | 2015 | 14 | 0.780 |
Why?
|
| Lysergic Acid Diethylamide | 1 | 2021 | 8 | 0.740 |
Why?
|
| Rett Syndrome | 2 | 2018 | 294 | 0.570 |
Why?
|
| Animals | 27 | 2025 | 36217 | 0.550 |
Why?
|
| Disease Models, Animal | 5 | 2018 | 4760 | 0.520 |
Why?
|
| Social Learning | 1 | 2016 | 7 | 0.520 |
Why?
|
| Observation | 1 | 2016 | 45 | 0.520 |
Why?
|
| Memory Disorders | 1 | 2018 | 235 | 0.500 |
Why?
|
| Mental Recall | 1 | 2017 | 144 | 0.500 |
Why?
|
| Interneurons | 3 | 2022 | 147 | 0.480 |
Why?
|
| Fear | 1 | 2017 | 205 | 0.480 |
Why?
|
| Rats, Long-Evans | 5 | 2021 | 103 | 0.460 |
Why?
|
| Sleep Stages | 1 | 2014 | 33 | 0.440 |
Why?
|
| Tauopathies | 1 | 2015 | 78 | 0.440 |
Why?
|
| Theta Rhythm | 3 | 2025 | 24 | 0.420 |
Why?
|
| Receptors, Nicotinic | 4 | 2002 | 139 | 0.410 |
Why?
|
| Models, Animal | 2 | 2013 | 483 | 0.390 |
Why?
|
| Pyramidal Cells | 3 | 2016 | 172 | 0.350 |
Why?
|
| Memory | 3 | 2018 | 358 | 0.340 |
Why?
|
| Neurodegenerative Diseases | 1 | 2013 | 284 | 0.330 |
Why?
|
| Neuronal Plasticity | 3 | 2018 | 288 | 0.310 |
Why?
|
| Spatial Learning | 2 | 2021 | 16 | 0.300 |
Why?
|
| Disease Progression | 1 | 2015 | 2246 | 0.300 |
Why?
|
| Nerve Net | 2 | 2025 | 262 | 0.290 |
Why?
|
| Nonlinear Dynamics | 1 | 2008 | 53 | 0.290 |
Why?
|
| Neural Inhibition | 2 | 2016 | 110 | 0.280 |
Why?
|
| Learning | 2 | 2022 | 375 | 0.260 |
Why?
|
| Models, Neurological | 3 | 2025 | 220 | 0.260 |
Why?
|
| Electromyography | 2 | 2021 | 141 | 0.240 |
Why?
|
| Entorhinal Cortex | 2 | 2022 | 22 | 0.230 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2018 | 312 | 0.220 |
Why?
|
| Acetylcholine | 2 | 2001 | 86 | 0.220 |
Why?
|
| Maze Learning | 2 | 2022 | 126 | 0.210 |
Why?
|
| Long-Term Potentiation | 2 | 2022 | 163 | 0.210 |
Why?
|
| Mice, Transgenic | 4 | 2025 | 2524 | 0.200 |
Why?
|
| Orientation | 1 | 2022 | 47 | 0.200 |
Why?
|
| Space Perception | 1 | 2022 | 63 | 0.190 |
Why?
|
| Brain Waves | 1 | 2023 | 48 | 0.190 |
Why?
|
| Mice | 10 | 2025 | 18936 | 0.190 |
Why?
|
| Reward | 2 | 2021 | 120 | 0.180 |
Why?
|
| Fluorobenzenes | 1 | 2021 | 39 | 0.180 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 150 | 0.170 |
Why?
|
| Synapses | 2 | 2022 | 470 | 0.170 |
Why?
|
| Male | 11 | 2025 | 65576 | 0.160 |
Why?
|
| Piperidines | 1 | 2021 | 241 | 0.160 |
Why?
|
| tau Proteins | 2 | 2025 | 240 | 0.130 |
Why?
|
| Fornix, Brain | 1 | 2016 | 20 | 0.130 |
Why?
|
| Avoidance Learning | 1 | 2017 | 59 | 0.130 |
Why?
|
| Electric Stimulation | 1 | 2017 | 288 | 0.130 |
Why?
|
| Temporal Lobe | 1 | 2016 | 118 | 0.120 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 99 | 0.120 |
Why?
|
| Spatial Navigation | 1 | 2014 | 23 | 0.110 |
Why?
|
| Amyloidosis | 1 | 2014 | 73 | 0.100 |
Why?
|
| Periodicity | 2 | 2023 | 52 | 0.100 |
Why?
|
| Neural Pathways | 1 | 2014 | 283 | 0.100 |
Why?
|
| Algorithms | 1 | 2018 | 1730 | 0.090 |
Why?
|
| Mecamylamine | 2 | 2001 | 10 | 0.090 |
Why?
|
| Nicotinic Antagonists | 2 | 2001 | 10 | 0.090 |
Why?
|
| Bicuculline | 2 | 2001 | 21 | 0.090 |
Why?
|
| Deep Brain Stimulation | 1 | 2016 | 427 | 0.090 |
Why?
|
| Nicotine | 2 | 2002 | 142 | 0.080 |
Why?
|
| Mice, Knockout | 1 | 2018 | 3979 | 0.080 |
Why?
|
| Patch-Clamp Techniques | 2 | 2001 | 300 | 0.080 |
Why?
|
| Phenotype | 2 | 2018 | 4577 | 0.080 |
Why?
|
| In Vitro Techniques | 2 | 2001 | 961 | 0.080 |
Why?
|
| Female | 7 | 2018 | 71482 | 0.070 |
Why?
|
| Exploratory Behavior | 1 | 2008 | 54 | 0.070 |
Why?
|
| Task Performance and Analysis | 1 | 2008 | 91 | 0.070 |
Why?
|
| Cell Count | 1 | 2006 | 235 | 0.060 |
Why?
|
| Probability | 1 | 2006 | 327 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2006 | 256 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 4823 | 0.060 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 2 | 2002 | 59 | 0.060 |
Why?
|
| Amino Acid Substitution | 2 | 2002 | 415 | 0.050 |
Why?
|
| Heterozygote | 2 | 2002 | 731 | 0.050 |
Why?
|
| Ganglionic Stimulants | 1 | 2002 | 11 | 0.050 |
Why?
|
| Electroencephalography | 1 | 2006 | 896 | 0.050 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 2001 | 14 | 0.050 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2001 | 15 | 0.050 |
Why?
|
| Tobacco Use Disorder | 1 | 2001 | 88 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2001 | 396 | 0.040 |
Why?
|
| Aconitine | 1 | 2000 | 9 | 0.040 |
Why?
|
| GABA Antagonists | 1 | 2000 | 20 | 0.040 |
Why?
|
| Alzheimer Disease | 2 | 2014 | 882 | 0.040 |
Why?
|
| Tetrodotoxin | 1 | 2000 | 53 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2001 | 316 | 0.040 |
Why?
|
| Receptors, GABA-A | 1 | 2000 | 59 | 0.040 |
Why?
|
| Point Mutation | 1 | 2001 | 358 | 0.040 |
Why?
|
| Dopamine | 1 | 2001 | 285 | 0.040 |
Why?
|
| Humans | 5 | 2024 | 133331 | 0.040 |
Why?
|
| Silicon | 1 | 2018 | 12 | 0.040 |
Why?
|
| Computer Graphics | 1 | 2018 | 40 | 0.040 |
Why?
|
| Synaptic Transmission | 1 | 2000 | 365 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2000 | 1303 | 0.030 |
Why?
|
| Perforant Pathway | 1 | 2016 | 13 | 0.030 |
Why?
|
| Seizures | 1 | 2002 | 889 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2016 | 122 | 0.030 |
Why?
|
| Mosaicism | 1 | 2016 | 249 | 0.030 |
Why?
|
| Gene Duplication | 1 | 2016 | 372 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2014 | 164 | 0.030 |
Why?
|
| Environment | 1 | 2014 | 154 | 0.030 |
Why?
|
| Homeostasis | 1 | 2016 | 748 | 0.020 |
Why?
|
| Brain | 1 | 2023 | 3223 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 6544 | 0.020 |
Why?
|
| Dihydro-beta-Erythroidine | 1 | 2002 | 4 | 0.010 |
Why?
|
| Neuroanatomy | 1 | 2002 | 13 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 6343 | 0.010 |
Why?
|
| Threonine | 1 | 2002 | 63 | 0.010 |
Why?
|
| Limbic System | 1 | 2001 | 23 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2002 | 281 | 0.010 |
Why?
|
| Nicotinic Agonists | 1 | 2001 | 45 | 0.010 |
Why?
|
| Lysine | 1 | 2002 | 207 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2001 | 481 | 0.010 |
Why?
|